Olivier Gouédard
Directeur des opérations chez Cytovia Therapeutics, Inc.
Postes actifs de Olivier Gouédard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Directeur des opérations | 22/06/2021 | - |
Historique de carrière de Olivier Gouédard
Formation de Olivier Gouédard
| New York University | Masters Business Admin |
| Université Paris-Saclay | Undergraduate Degree |
| University of Rennes | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| France | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Olivier Gouédard
- Expérience
